
Lexicon Pharmaceuticals, Inc.: shareholders and insiders
Price
$1.65
November 20, 2026Market cap $735M
What Ploutos Investor adds for Lexicon Pharmaceuticals
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 20, 2025 to Nov 9, 2026, from their own Form 4 filings.
Bought on the market
$2.8M
3 people
Sold on the market
–
nobody
From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
- Nov 6, 2026Michael ExtonChief Executive OfficerKind
- Jun 3, 2026Judith L SwainDirectorKind
- Jun 3, 2026Diane E. SullivanDirectorKind
- Jun 3, 2026Christopher J SobeckiDirectorKind
- Jun 3, 2026Ivan CheungDirectorKind
- Jun 3, 2026Sam L BarkerDirectorKind
- Jun 3, 2026Philippe AmouyalDirectorKind
- Jun 3, 2026Raymond DebbaneDirectorKind
- Feb 25, 2026Raymond DebbaneKind
- Feb 23, 2026Raymond DebbaneKind
- Feb 20, 2026Raymond DebbaneKind
- Feb 19, 2026Raymond DebbaneKind
- Feb 18, 2026Raymond DebbaneKind
- Feb 17, 2026Raymond DebbaneKind
- Feb 13, 2026Raymond DebbaneKind
- Feb 2, 2026Artal Group S.A.Kind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | Michael ExtonChief Executive Officer | 30.1K | $1.66 | $50.0K | Form 4 | |
| Jun 3, 2026 | Judith L SwainDirector | 89.3K | – | – | Form 4 | |
| Jun 3, 2026 | Diane E. SullivanDirector | 89.3K | – | – | Form 4 | |
| Jun 3, 2026 | Christopher J SobeckiDirector | 89.3K | – | – | Form 4 | |
| Jun 3, 2026 | Ivan CheungDirector | 89.3K | – | – | Form 4 | |
| Jun 3, 2026 | Sam L BarkerDirector | 89.3K | – | – | Form 4 | |
| Jun 3, 2026 | Philippe AmouyalDirector | 89.3K | – | – | Form 4 | |
| Jun 3, 2026 | Raymond DebbaneDirector | 89.3K | – | – | Form 4 | |
| Feb 25, 2026 | Raymond Debbane | 2,000 | $1.49 | $3.0K | Form 4 | |
| Feb 23, 2026 | Raymond Debbane | 100.0K | $1.47 | $147.0K | Form 4 | |
| Feb 20, 2026 | Raymond Debbane | 100.0K | $1.48 | $148.0K | Form 4 | |
| Feb 19, 2026 | Raymond Debbane | 50.0K | $1.44 | $72.0K | Form 4 | |
| Feb 18, 2026 | Raymond Debbane | 133.7K | $1.32 | $176.5K | Form 4 | |
| Feb 17, 2026 | Raymond Debbane | 76.9K | $1.31 | $100.7K | Form 4 | |
| Feb 13, 2026 | Raymond Debbane | 58.0K | $1.31 | $75.9K | Form 4 | |
| Feb 2, 2026 | Artal Group S.A. | 1.54M | $1.30 | $2.0M | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 4, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by LXRX's officers and directors from 2005 up to November 19, 2025, 21 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 16 more, back to 2005
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Invus, L.P.39.4%From the filing of May 8, 2026
Item 4 of the Statement is hereby amended and supplemented as follows: As previously disclosed in Amendment No. 25, on February 2, 2026, Artal Participations S.a.r.l. acquired 367,145.12 shares of Preferred Stock, and on February 17, 2026 Artal Participations S.a r.l. purchased an additional 41,289.58 shares of Preferred Stock, in each case, pursuant to the terms of the Preferred Purchase Agreement. Each share of Preferred Stock would automatically convert into 50 shares (subject to adjustments) of Issuer Common Stock immediately following the satisfaction of all of the following conditions: (i) the approval of the New Charter by the shareholders of the Issuer at the Annual Meeting; (ii)…
From the filing of May 8, 2026
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter-88%
- Citadel Advisors (Griffin)In the quarter-9.1%
- Millennium Mgmt (Englander)In the quarter-31%
- D.E. ShawIn the quarter+172%
- Renaissance TechnologiesIn the quarter
- AQR CapitalIn the quarter-16%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | 988.3K | -88% | $1.9M | 0.00% |
| Citadel Advisors (Griffin) | 1.46M | -9.1% | $2.7M | 0.00% |
| Millennium Mgmt (Englander) | 786.0K | -31% | $1.5M | 0.00% |
| D.E. Shaw | 60.4K | +172% | $100.0K | 0.00% |
| Renaissance Technologies | – | – | 0.00% | |
| AQR Capital | 62.9K | -16% | $100.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 6.00% of its shares outstanding were held short, +3.4% since the report before.
- Shares held short
- 26.70M
- 6.00%
- Since the report before25.83M on Sep 30, 2026
- +3.4%
- 13.0
- 2.06M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 97%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 21.98M
- Nov 15, 2023: Shares held short 22.37M
- Nov 30, 2023: Shares held short 23.40M
- Dec 15, 2023: Shares held short 23.28M
- Dec 29, 2023: Shares held short 23.22M
- Jan 12, 2024: Shares held short 25.27M
- Jan 31, 2024: Shares held short 23.03M
- Feb 15, 2024: Shares held short 23.41M
- Feb 29, 2024: Shares held short 21.07M
- Mar 15, 2024: Shares held short 21.35M
- Mar 28, 2024: Shares held short 21.91M
- Apr 15, 2024: Shares held short 20.12M
- Apr 30, 2024: Shares held short 23.44M
- May 15, 2024: Shares held short 23.27M
- May 31, 2024: Shares held short 25.14M
- Jun 14, 2024: Shares held short 21.57M
- Jun 28, 2024: Shares held short 20.20M
- Jul 15, 2024: Shares held short 20.88M
- Jul 31, 2024: Shares held short 22.35M
- Aug 15, 2024: Shares held short 24.53M
- Aug 30, 2024: Shares held short 25.39M
- Sep 13, 2024: Shares held short 26.63M
- Sep 30, 2024: Shares held short 26.97M
- Oct 15, 2024: Shares held short 27.65M
- Oct 31, 2024: Shares held short 28.65M
- Nov 15, 2024: Shares held short 31.38M
- Nov 29, 2024: Shares held short 31.53M
- Dec 13, 2024: Shares held short 31.28M
- Dec 31, 2024: Shares held short 33.50M
- Jan 15, 2025: Shares held short 39.10M
- Jan 31, 2025: Shares held short 43.03M
- Feb 14, 2025: Shares held short 44.74M
- Feb 28, 2025: Shares held short 47.46M
- Mar 14, 2025: Shares held short 39.26M
- Mar 31, 2025: Shares held short 43.88M
- Apr 15, 2025: Shares held short 41.33M
- Apr 30, 2025: Shares held short 37.27M
- May 15, 2025: Shares held short 43.03M
- May 30, 2025: Shares held short 38.83M
- Jun 13, 2025: Shares held short 37.56M
- Jun 30, 2025: Shares held short 33.21M
- Jul 15, 2025: Shares held short 29.21M
- Jul 31, 2025: Shares held short 27.06M
- Aug 15, 2025: Shares held short 27.91M
- Aug 29, 2025: Shares held short 28.84M
- Sep 15, 2025: Shares held short 28.38M
- Sep 30, 2025: Shares held short 27.30M
- Oct 15, 2025: Shares held short 26.83M
- Oct 31, 2025: Shares held short 27.70M
- Nov 14, 2025: Shares held short 24.65M
- Nov 28, 2025: Shares held short 24.23M
- Dec 15, 2025: Shares held short 23.34M
- Dec 31, 2025: Shares held short 23.66M
- Jan 15, 2026: Shares held short 25.16M
- Jan 30, 2026: Shares held short 24.58M
- Feb 13, 2026: Shares held short 24.52M
- Feb 27, 2026: Shares held short 23.14M
- Mar 13, 2026: Shares held short 22.69M
- Mar 31, 2026: Shares held short 22.93M
- Apr 15, 2026: Shares held short 23.67M
- Apr 30, 2026: Shares held short 23.86M
- May 15, 2026: Shares held short 26.14M
- May 29, 2026: Shares held short 26.21M
- Jun 15, 2026: Shares held short 25.43M
- Jun 30, 2026: Shares held short 30.78M
- Jul 15, 2026: Shares held short 32.73M
- Jul 31, 2026: Shares held short 32.83M
- Aug 14, 2026: Shares held short 32.75M
- Aug 31, 2026: Shares held short 29.49M
- Sep 15, 2026: Shares held short 28.79M
- Sep 30, 2026: Shares held short 25.83M
- Oct 15, 2026: Shares held short 26.70M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading60.1% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 60.1% of the shares in the reported trades were short sales, against 63.3% in the 14 before.
- Last 14 sessionsNov 2, 2026 – Nov 19, 2026
- 60.1%
- The 14 beforeOct 13, 2026 – Oct 30, 2026
- 63.3%
- Change
- -3.2 pts
- Short sales a dayon average, of 923.1K shares
- 554.5K
- More than atof 3,666 US-listed companies, same days
- 83%
- Median of alleight in ten from 34.5% to 63.8%
- 50.4%
- Short sales
- Oct 13, 2026: Short sales 62.3%
- Oct 14, 2026: Short sales 62.6%
- Oct 15, 2026: Short sales 53.5%
- Oct 16, 2026: Short sales 69.4%
- Oct 19, 2026: Short sales 68.2%
- Oct 20, 2026: Short sales 72.8%
- Oct 21, 2026: Short sales 78.8%
- Oct 22, 2026: Short sales 51.8%
- Oct 23, 2026: Short sales 47.9%
- Oct 26, 2026: Short sales 78.4%
- Oct 27, 2026: Short sales 72.2%
- Oct 28, 2026: Short sales 59.1%
- Oct 29, 2026: Short sales 44.2%
- Oct 30, 2026: Short sales 68.8%
- Nov 2, 2026: Short sales 62.1%
- Nov 3, 2026: Short sales 77%
- Nov 4, 2026: Short sales 57.1%
- Nov 5, 2026: Short sales 47.1%
- Nov 6, 2026: Short sales 56.4%
- Nov 9, 2026: Short sales 62.4%
- Nov 10, 2026: Short sales 68%
- Nov 11, 2026: Short sales 56.6%
- Nov 12, 2026: Short sales 66.1%
- Nov 13, 2026: Short sales 66.1%
- Nov 16, 2026: Short sales 66.8%
- Nov 17, 2026: Short sales 47%
- Nov 18, 2026: Short sales 64.5%
- Nov 19, 2026: Short sales 71.9%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Raymond DebbaneDirectorDirectly51.75M
- Artal Group S.A.Director,TenPercentOwnerDirectly–
- Philippe AmouyalDirectorDirectly374.5K
- Michael ExtonChief Executive OfficerDirectly328.5K
- Christopher J SobeckiDirectorDirectly293.2K
- Sam L BarkerDirectorDirectly213.8K
- Judith L SwainDirectorDirectly174.5K
- Diane E. SullivanDirectorDirectly126.1K
- Ivan CheungDirectorDirectly89.3K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Raymond DebbaneDirector | 51.75M | – | Jun 3, 2026 | Form 4 |
| Artal Group S.A.Director,TenPercentOwner | – | 1.54M | Feb 2, 2026 | Form 4 |
| Philippe AmouyalDirector | 374.5K | – | Jun 3, 2026 | Form 4 |
| Michael ExtonChief Executive Officer | 328.5K | – | Nov 6, 2026 | Form 4 |
| Christopher J SobeckiDirector | 293.2K | – | Jun 3, 2026 | Form 4 |
| Sam L BarkerDirector | 213.8K | – | Jun 3, 2026 | Form 4 |
| Judith L SwainDirector | 174.5K | – | Jun 3, 2026 | Form 4 |
| Diane E. SullivanDirector | 126.1K | – | Jun 3, 2026 | Form 4 |
| Ivan CheungDirector | 89.3K | – | Jun 3, 2026 | Form 4 |
A lower bound: it counts only the 9 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.13%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.04%
- IWMiShares Russell 2000 ETFWeight in the fund0.02%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.02%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.01%
- VHTVanguard Health Care Index FundWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.01%
- IWViShares Russell 3000 ETFWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
- SCHBSchwab U.S. Broad Market ETFWeight in the fund0.00%
10 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 123
- Q4 2025: Managers 125
- Q1 2026: Managers 137
- Q2 2026: Managers 149
Institutional investors by quarter
The fund managers holding LXRX, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 149 managers held 365M shares, worth $875M. During the quarter 45 opened a position, 33 closed one, 34 added and 35 trimmed.
The largest holders, Q2 2026
- Artal GroupIn the quarter+13%
- FMRIn the quarter+15%
- SirenIn the quarter
- Sessa Capital IMIn the quarter+5.8%
- BlackRockIn the quarter+422%
- Vanguard Capital ManagementIn the quarter+4.0%
- Point72 (Cohen)In the quarter+5.6%
- Geode Capital ManagementIn the quarter+97%
- State StreetIn the quarter+410%
- Vanguard Portfolio ManagementIn the quarter+331%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Artal Group | 175M | +13% | $420M |
| FMR | 51.78M | +15% | $124M |
| Siren | 44.30M | $106M | |
| Sessa Capital IM | 18.96M | +5.8% | $46M |
| BlackRock | 17.35M | +422% | $42M |
| Vanguard Capital Management | 9.90M | +4.0% | $24M |
| Point72 (Cohen) | 8.25M | +5.6% | $20M |
| Geode Capital Management | 6.24M | +97% | $15M |
| State Street | 4.92M | +410% | $12M |
| Vanguard Portfolio Management | 2.36M | +331% | $5.7M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Lexicon Pharmaceuticals's filings show?
Who buys and sells is one part of Lexicon Pharmaceuticals's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have LXRX's insiders bought or sold?
From Jun 4, 2026 to Nov 9, 2026 Lexicon Pharmaceuticals's insiders bought $50.0K and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.
Which well-known managers hold LXRX?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $2.7M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.